ask="1.0000"
ask_size="500"
average_daily_volume="114970"
bid="0.7000"
bid_size="200"
book_value="0.6940"
change="+0.0299"
change_from_200_day_moving_average="-0.3918"
change_from_50_day_moving_average="-0.1763"
change_from_52_week_high="-6.9501"
change_From_52_week_low="0.0999"
change_in_percent="+3.0825%"
close="0.9999"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.0100"
ebitda="-17.60M"
eps_estimate_current_year="-0.8200"
eps_estimate_next_quarter="-0.2200"
eps_estimate_next_year="-0.7300"
ex_dividend_date="N/A"
float_shares="6119000"
high="1.0700"
high_52_weeks="7.9500"
last_trade_date="3/10/2017"
last_trade_price="0.9999"
last_trade_size="1000"
last_trade_time="3:59pm"
low="0.9840"
low_52_weeks="0.9000"
market_capitalization="16.39M"
moving_average_200_day="1.3917"
moving_average_50_day="1.1762"
name="Bioblast Pharma Ltd. - Ordinary"
notes="N/A"
one_year_target_price="9.0000"
open="1.0700"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-28.1526%"
percent_change_from_50_day_moving_average="-14.9911%"
percent_change_from_52_week_high="-87.4226%"
percent_change_from_52_week_low="+11.1000%"
previous_close="0.9700"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.3977"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.2300"
stock_exchange="NGM"
symbol="ORPN"
volume="445898"
weeks_range_52="0.9000 - 7.9500"
